stockportfolio.pro
Avanos Medical, Inc. P/E Ratio 2012–2025
Avanos Medical, Inc. (AVNS) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -8.3%/yr over 13 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | — | — |
| FY 2023 | — | — |
| FY 2022 | 25.29 | -90.5% |
| FY 2021 | 266.69 | — |
| FY 2020 | — | — |
| FY 2019 | — | — |
| FY 2018 | 36.71 | +34.4% |
| FY 2017 | 27.33 | -37.2% |
| FY 2016 | 43.51 | — |
| FY 2015 | — | — |
| FY 2014 | 78.40 | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
Source: Avanos Medical, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Avanos Medical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAvanos Medical, Inc. — frequently asked questions
What is Avanos Medical, Inc.'s price-to-earnings ratio?
Avanos Medical, Inc. (AVNS) reported price-to-earnings ratio of 25.29 for fiscal year 2022, per its SEC filings.
How has Avanos Medical, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2012 and 2025, AVNS's price-to-earnings ratio declined at roughly 8.3% per year (compound annual rate), from 78.40 to 25.29.
Where does this data come from?
Figures are computed from Avanos Medical, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.